Aryl hydrocarbon receptor activation in chronic kidney disease: Role of uremic toxins - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement
Article Dans Une Revue (Article De Synthèse) Nephron Physiology Année : 2017

Aryl hydrocarbon receptor activation in chronic kidney disease: Role of uremic toxins

Résumé

The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor involved in the expression of xenobiotic-metabolizing enzymes, inflammatory cytokines and adhesion molecules. Uremic toxins such as indoxyl sulfate and indole acetic acid are derived from tryptophan fermentation by gut microbiota; they accumulate in patients with chronic kidney disease (CKD) on haemodialysis and have recently emerged as potent ligands of AhR. Therefore, AhR can serve as a mediator in inflammation and cardiovascular diseases in these patients. This review discusses current data that support a link between AhR activation and uremic toxins from gut microbiota in CKD.

Dates et versions

hal-02623789 , version 1 (26-05-2020)

Identifiants

Citer

Jessyca S. Brito, Natlaia A. Borges, Marta Esgalhado, d'Angelo C. Magliano, Christophe Soulage, et al.. Aryl hydrocarbon receptor activation in chronic kidney disease: Role of uremic toxins. Nephron Physiology, 2017, 137 (1), pp.1-7. ⟨10.1159/000476074⟩. ⟨hal-02623789⟩
19 Consultations
0 Téléchargements

Altmetric

Partager

More